Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mead Johnson Upbeat On China Outlook After Series Of Setbacks

This article was originally published in The Tan Sheet

Executive Summary

The infant nutritionals firm has put a poorly timed price increase behind it and is optimistic about the effects of a Hong Kong limit on formula exports on China sales. Additionally, a recall of Danone baby nutrition products in Asia is expected to benefit Mead Johnson over the next 9 to 12 months.

Advertisement

Related Content

Abbott Nutrition Sales Weakened By China Recall
Abbott Nutrition Sales Weakened By China Recall
Mead Johnson Milks Growth Of Emerging Market Middle Class
Mead Johnson Milks Growth Of Emerging Market Middle Class
Mead Johnson Milks Growth Of Emerging Markets’ Middle Class
Mead Johnson Milks Growth Of Emerging Markets’ Middle Class
In Brief: NAD trims BPI claims, formula price-fixing in China, FDA warns Formulife and identifies spiked supplements, NBTY’s consumer redress
In Brief
Danone Enters Infant Formula Market With Numico Acquisition

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106602

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel